Product Information
BUTALBITAL-ASPIRIN-CAFFEINE 50-325-40 MG CAPSULE is a generic product labeled by Chartwell RX LLC, priced at $0.9750 per EA under NDC 62135043390. Its NADAC has been published 169 times since Apr 5, 2023.
Strength
325; 50; 40 mg/1; mg/1; mg/1
Manufacturer
Chartwell RX LLCNDC
62135043390
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
ASPIRIN; BUTALBITAL; CAFFEINEApproval Type
Generic (ANDA)
FDA Application
ANDA086996On Market Since
10/11/1985
Pharmacological Classes
Price Statistics
The NADAC for BUTALBITAL-ASPIRIN-CAFFEINE 50-325-40 MG CAPSULE has been published 169 times since Apr 5, 2023, and over the history we have for it it has risen 36.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.9750 per EA |
|---|---|
| All-time high | $1.0486 (Sep 10, 2025) |
| All-time low | $0.3623 (Nov 20, 2024) |
| 52-week high | $1.0486 |
| 52-week low | $0.9704 |
| Median price | $0.7872 |
| Average price | $0.8112 |
| Largest weekly change | +59.7% (Dec 18, 2024) |
| Weeks tracked | 169 |
| Tracking since | Apr 5, 2023 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the butalbital, aspirin, and caffeine market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of BUTALBITAL-ASPIRIN-CAFFEINE 50-325-40 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for BUTALBITAL-ASPIRIN-CAFFEINE 50-325-40 MG CAPSULE, manufactured by Chartwell RX LLC, is $0.9750 per EA (NDC 62135043390), effective Jun 24, 2026.
How has the price of BUTALBITAL-ASPIRIN-CAFFEINE 50-325-40 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for BUTALBITAL-ASPIRIN-CAFFEINE 50-325-40 MG CAPSULE has risen 36.1%. It has been tracked across 169 weekly CMS publications since Apr 5, 2023.
What are the highest and lowest recorded NADAC prices for BUTALBITAL-ASPIRIN-CAFFEINE 50-325-40 MG CAPSULE?
Since Apr 5, 2023, the NADAC for BUTALBITAL-ASPIRIN-CAFFEINE 50-325-40 MG CAPSULE has ranged from a low of $0.3623 (Nov 20, 2024) to a high of $1.0486 (Sep 10, 2025), with a median of $0.7872 per EA.
Are there cheaper alternatives to BUTALBITAL-ASPIRIN-CAFFEINE 50-325-40 MG CAPSULE?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of BUTALBITAL-ASPIRIN-CAFFEINE 50-325-40 MG CAPSULE, so no direct lower-cost alternative is listed.
Who manufactures BUTALBITAL-ASPIRIN-CAFFEINE 50-325-40 MG CAPSULE?
BUTALBITAL-ASPIRIN-CAFFEINE 50-325-40 MG CAPSULE (NDC 62135043390) is labeled by Chartwell RX LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification